J. Fowler

发表

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Gr

B N Bundy, M Markman, D. Alberts, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial.

P. Lambin, J. Fowler, K. Haustermans, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?

E. Eisenhauer, D. Cohn, R. Salani, 2012, Gynecologic oncology.

Response to Dr. Carter's letter to the editor regarding "Short and long term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging".

F. Backes, J. Fowler, 2013, Gynecologic oncology.

Comprehensive Surgical Staging for Endometrial Cancer in Obese Patients: Comparing Robotics and Laparotomy

G. Phillips, D. Cohn, W. Huh, 2009, Obstetrics and gynecology.

Lymphadenectomy for endometrial cancer: the controversy.

D. Cohn, J. Fowler, L. Seamon, 2010, Gynecologic oncology.

Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.

B. Monk, R. Burger, S. Rubin, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.

W. E. Richards, D. Matei, D. Mutch, 2021, Gynecologic oncology.

Pain in the Foot: Calcaneal Metastasis as the Presenting Feature of Endometrial Cancer

N. Gupta, R. Gahbauer, J. Fowler, 2002, Obstetrics and gynecology.

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations.

L. Senter, David W. Cohen, D. Cohn, 2020, Surgical oncology.

Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?

N. Ramirez, D. Cohn, J. Fowler, 2003, Gynecologic oncology.

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

D. Cohn, R. Salani, F. Backes, 2016, International Journal of Gynecologic Cancer.

Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.

E. Hade, J. Benedict, D. Cohn, 2020, American journal of obstetrics and gynecology.

Surgical Staging for Patients Presenting With Grade 1 Endometrial Carcinoma

N. Ramirez, J. Pavelka, D. Cohn, 2005, Obstetrics and gynecology.

Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer

D. Mutch, N. Horowitz, D. Cohn, 2002 .

The Use of Transvaginal Ultrasound in Type II Endometrial Cancer

D. Cohn, R. Salani, F. Backes, 2015, International Journal of Gynecologic Cancer.

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.

E. Eisenhauer, D. Cohn, R. Salani, 2011, Gynecologic oncology.

Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.

R. Kryscio, Simon A. Smith, H. Gallion, 2002, Gynecologic oncology.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Annette Lee, W. Chung, R. Nussbaum, 2018, Human mutation.

Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.

P. Goodfellow, W. Frankel, A. de la Chapelle, 2020, Gynecologic oncology.

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort

D. Cohn, R. Holloway, R. Salani, 2016, International Journal of Gynecologic Cancer.

The role of robotic surgery in endometrial cancer

J. Fowler, Blair Smith, David O’Malley, 2015, Journal of surgical oncology.

Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

S. Waggoner, P. Rose, I. Horowitz, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.

L. Twiggs, K. Dusenbery, P. Holt, 1994, International journal of radiation oncology, biology, physics.

Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study.

B. Monk, R. Burger, M. Brady, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of laparoscopic staging in the management of patients with early endometrial cancer.

J. Fowler, 1999, Gynecologic oncology.

Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?

G. Phillips, D. Cohn, Jeffrey M Fowler, 2009, Gynecologic oncology.

Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging.

D. Cohn, R. Holloway, F. Backes, 2012, Gynecologic oncology.

The Role of Robotic Surgery in Treatment of Gynecologic Cancers: Part I General Principles

F. Backes, J. Fowler, 2011 .

The Role of Robotic Surgery in Treatment of Gynecologic Cancers Part II: Specific Treatments

F. Backes, J. Fowler, 2011 .

Robotic pelvic and aortic lymphadenectomy for endometrial cancer: the console surgeon's perspectives on surgical technique and directing the assistant.

D. Cohn, J. Fowler, D. Richardson, 2010, Journal of minimally invasive gynecology.

Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success—the Ohio State University method

D. Cohn, J. Fowler, D. Richardson, 2008, Journal of Robotic Surgery.

Who will be readmitted? Evaluation of the laparoscopic hysterectomy readmission score in a gynecologic oncology population undergoing robotic-assisted hysterectomy.

D. Cohn, R. Salani, F. Backes, 2021, Gynecologic oncology.

Late side effects of robotic surgery.

F. Backes, J. Fowler, 2016, Gynecologic oncology.

Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancer.

E. Hade, E. Eisenhauer, D. Cohn, 2015, Journal of minimally invasive gynecology.

Quality of Life Assessment in Gynaecological Cancer Patients

L. Twiggs, P. Carney, J. Carter, 1995, The Australian & New Zealand journal of obstetrics & gynaecology.

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

P. Fracasso, S. Waggoner, G. Sutton, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.

L. Twiggs, J. Carlson, J. Carter, 1994, Gynecologic oncology.

Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.

A. Berchuck, L. Havrilesky, B. Davidson, 2020, Gynecologic oncology.

Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.

E. Hade, D. Cohn, R. Salani, 2015, Gynecologic oncology.

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

R. Burger, Joan L. Walker, D. Armstrong, 2006, Gynecologic oncology.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Robert S Mannel, R. Burger, R. Ozols, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Borderline and invasive epithelial ovarian tumors in young women

L. Twiggs, J. Carlson, J. Carter, 1993, Obstetrics and gynecology.

Peritoneal adenocarcinoma (serous) of Müllerian type: a subgroup of women presenting with peritoneal carcinomatosis

J. Berek, R. Nieberg, J. Fowler, 1993, International Journal of Gynecologic Cancer.

Robotic Hysterectomy and Pelvic–Aortic Lymphadenectomy for Endometrial Cancer

G. Phillips, D. Cohn, Jeffrey M Fowler, 2008, Obstetrics and gynecology.

The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis.

J Michael Straughn, S. Modesitt, S. Rose, 2017, Gynecologic oncology.

Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.

Pedro F Escobar, P. Escobar, A. Secord, 2012, Gynecologic oncology.

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.

T. Herzog, E. Partridge, R. Alvarez, 2003, Gynecologic oncology.

Incisional bowel herniations after operative laparoscopy: a series of nineteen cases and review of the literature.

N. Spirtos, J. Fowler, J. Orr, 1995, American journal of obstetrics and gynecology.

Gray scale and color flow Doppler characterization of uterine tumors.

L. Twiggs, J. Carlson, J. Carter, 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

The Role of Operative Laparoscopy in Gynecologic Oncology

E. Hartenbach, J. Fowler, 1996, Diagnostic and therapeutic endoscopy.

Incorporating pelvic/vaginal reconstruction into radical pelvic surgery.

J. Fowler, 2009, Gynecologic oncology.

Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update.

L. Twiggs, J. Carlson, J. Carter, 1996, Gynecologic oncology.

Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?

R. Bahnson, E. Eisenhauer, D. Cohn, 2012, Gynecologic oncology.

Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study.

Danielle M. Enserro, B. Monk, R. Burger, 2018 .

A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study

R. Burger, D. Cella, P. Disaia, 2017 .

Laparoscopy versus laparotomy: an evaluation of adhesion formation after pelvic and paraaortic lymphadenectomy in a porcine model.

J. Fowler, M. Chen, Peter R. Johnson, 1998, American journal of obstetrics and gynecology.

Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study.

L. Twiggs, J. Carlson, J. Carter, 1993, Gynecologic oncology.

Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: a gynecologic oncology group study.

R. Burger, J. Fowler, J. Blessing, 2002, Gynecologic oncology.

Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model.

L. Twiggs, J. Carlson, J. Carter, 1994, Gynecologic oncology.

Laparoscopic para-aortic lymph node sampling: development of a technique.

J. Fowler, D. Shenson, F. Montz, 1992, Gynecologic oncology.

Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors

L. Twiggs, J. Carlson, J. Carter, 1992, International Journal of Gynecologic Cancer.

Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs.

L. Twiggs, D. Hunter, J. Carlson, 1995, Gynecologic oncology.

Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.

E. Hade, D. Cohn, R. Salani, 2019, Gynecologic oncology.

Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.

H. Muss, T. Burke, J. Fowler, 1996, Gynecologic oncology.

Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block.

K. Dusenbery, D. Roback, J. Carlson, 1994, International journal of radiation oncology, biology, physics.

Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.

J. Carlson, J. Fowler, L. Carson, 1997, Gynecologic oncology.

Endometrial cancer staging in the elderly: Robotic or open?

E. Eisenhauer, D. Cohn, R. Holloway, 2012 .

Ureteroarterial fistula following retrograde ureteral stenting in a patient with a double-barreled wet colostomy for cervical cancer☆

J. Fowler, J. Dowell, B. Tierney, 2015, Gynecologic oncology reports.

Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?

E. Eisenhauer, D. Cohn, R. Salani, 2014, Gynecologic oncology.

A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch).

L. Twiggs, P. Paley, J. Carter, 1997, Gynecologic oncology.

Stage IV endometrial cancer after failed conservative management: a case report.

D. Cohn, D. O’Malley, J. Fowler, 2008, Gynecologic oncology.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

W. Cliby, M. Spillman, L. Havrilesky, 2013, Gynecologic oncology.

Alternatives to commonly used pelvic reconstruction procedures in gynecologic oncology.

J. Fowler, G. McCann, A. Chao, 2014, Gynecologic oncology.

Rectus abdominis myocutaneous flap for primary vaginal reconstruction.

L. Twiggs, J. Carlson, J. Carter, 1993, Gynecologic oncology.

Persistent Postmolar Gestational Trophoblastic Disease: Use of Transvaginal Sonography and Colour Flow Doppler

L. Twiggs, J. Carlson, J. Carter, 1993, The Australian & New Zealand journal of obstetrics & gynaecology.

Transvaginal color flow Doppler sonography in the assessment of gestational trophoblastic disease

L. Twiggs, J. Carlson, J. Carter, 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Uterine lipoleiomyoma: a rare tumor

T. Okagaki, J. Carter, J. Fowler, 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

G. Phillips, D. Cohn, R. Salani, 2017, Gynecologic oncology.

How accurate is the pelvic examination as compared to transvaginal sonography? A prospective, comparative study.

L. Twiggs, J. Carlson, J. Carter, 1994, The Journal of reproductive medicine.

Increased Serum Inhibin Associated with Ovarian Fibroma Neoplasms

J. Fowler, L. Copeland, C. Cosgrove, 2016 .

Invasive vulvar tumors in young women--a disease of the immunosuppressed?

L. Twiggs, J. Carlson, J. Carter, 1993, Gynecologic oncology.

Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.

E. Hade, D. Cohn, R. Salani, 2017, Gynecologic oncology.

Bilateral groin reconstruction with a single anterolateral thigh perforator flap as an alternative to traditional myocutaneous flaps

J. Fowler, G. McCann, A. Chao, 2014, Gynecologic oncology case reports.

The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy.

L. Twiggs, P. Paley, J. Fowler, 1997, Gynecologic oncology.

Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy.

J. Fowler, Douglas D. Martin, D. Richardson, 2009, Gynecologic oncology.

Natural History of the Minimally Abnormal Papanicolaou Smear

B. Monk, F. Montz, J. Fowler, 1992, Obstetrics and Gynecology.

Evaluation of the immunogenicity of peptide and DNA constructs for HER-2/neu epitopes

Hao-Tian Jiang, J. Fowler, C. Walker, 2002 .

Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?

D. Mutch, N. Horowitz, D. Cohn, 2003, Gynecologic oncology.

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

W. Frankel, H. Hampel, Marino E. Leon, 2009, Gynecologic oncology.

Sentinel node (SN) biopsy in patients with vulvar cancer: A Gynecologic Oncology Group (GOG) study.

R. Coleman, P. Judson, J. Fowler, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of the Effects of Severe Obesity and Lifestyle Risk Factors On Stage of Endometrial Cancer

E. Paskett, J. Fisher, G. Maxwell, 2012, Cancer Epidemiology, Biomarkers & Prevention.

A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.

C. Weghorst, E. Paskett, G. Stoner, 2011, Gynecologic oncology.

Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.

D. Cohn, R. Salani, F. Backes, 2014, Gynecologic oncology.

Laparoscopic staging of endometrial cancer.

J. Fowler, 1996, Clinical obstetrics and gynecology.

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.

W. Frankel, A. de la Chapelle, H. Nakagawa, 2006, Cancer research.

Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer

Jian Z. Wang, W. Yuh, M. Knopp, 2009, Investigative radiology.

Incorporation of bevacizumab in the primary treatment of ovarian cancer.

B. Monk, R. Burger, M. Birrer, 2011, The New England journal of medicine.

CASE REPORT Chylous Ascites Following Treatment for Gynecologic Malignancies

J. Fowler, S. Abdessalam, T. Manolitsas, 2002 .

CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.

D. Cohn, D. O’Malley, J. Fowler, 2008, Gynecologic oncology.

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.

T. Herzog, E. Partridge, R. Alvarez, 2004, Gynecologic oncology.

Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer.

D. Cohn, J. Fowler, L. Copeland, 2006, Gynecologic oncology.

Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation

E. Eisenhauer, C. Lynch, D. Cohn, 2015, International Journal of Gynecologic Cancer.

The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model.

F. Montz, M. Mohler, J. Fowler, 1991, American journal of obstetrics and gynecology.

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model.

B. Monk, F. Montz, J. Fowler, 1993, Gynecologic oncology.

The inability of Gore-Tex Surgical Membrane to inhibit post-radical pelvic surgery adhesions in the dog model.

F. Montz, J. Fowler, S. Lacy, 1991, Gynecologic oncology.

Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incision.

D. Cohn, D. Young, J. Fowler, 2003, American journal of obstetrics and gynecology.

Cancer in the Pregnant Patient

D. O’Malley, J. Fowler, Kenneth H. Kim, 2011 .

A Single-Institution Approach to Total Pelvic Exenteration

R. Bahnson, E. Martin, D. Cohn, 2011, The American surgeon.

Changes in the burnout profile of chairs of academic departments of obstetrics and gynecology over the past 15 years

S. Gabbe, S. Moffatt-Bruce, J. Fowler, 2018, American journal of obstetrics and gynecology.

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

D. Alberts, R. Burger, E. Trimble, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

B. Monk, T. Kolevska, M. Morgan, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma

G. Phillips, A. Mariani, L. Havrilesky, 2007, Obstetrics and gynecology.

A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study

B. Monk, M. Morgan, C. Aghajanian, 2017 .

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

Katherine M. Tucker, W. Chung, R. Nussbaum, 2018, Journal of the National Cancer Institute.

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.

D. Mutch, Austin Miller, N. Horowitz, 2018, Gynecologic oncology.

Cost-Effectiveness Analysis of Strategies for the Surgical Management of Grade 1 Endometrial Adenocarcinoma

D. Cohn, W. Huh, J. Straughn, 2007, Obstetrics and gynecology.

Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications

D. Cohn, R. Salani, F. Backes, 2015, International Journal of Gynecologic Cancer.

Burnout and associated factors among members of the Society of Gynecologic Oncology.

G. Phillips, K. Carpenter, J. Fowler, 2015, American journal of obstetrics and gynecology.

A detailed analysis of the learning curve: robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.

G. Phillips, D. Cohn, J. Fowler, 2009, Gynecologic oncology.

Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.

D. Cohn, R. Salani, F. Backes, 2019, Gynecologic oncology.

Time to consider integration of a formal robotic-assisted surgical training program into obstetrics/gynecology residency curricula

E. Hade, R. Salani, J. Fowler, 2018, Journal of Robotic Surgery.

Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.

D. Cohn, R. Salani, F. Backes, 2016, Gynecologic oncology.

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.

C. Morrison, N. Ramirez, V. Zanagnolo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

21 – Role of Minimally Invasive Surgery in Gynecologic Malignancies

R. Mannel, D. Cohn, F. Backes, 2018 .

Role of Minimally Invasive Surgery in Gynecologic Malignancies

R. Mannel, D. Cohn, J. Fowler, 2012 .

Chapter 52 – The Role of Laparoscopy in the Management of Gynecologic Cancers

J. Fowler, I. Ben-shachar, I. Ben‐Shachar, 2004 .

Role of Laparoscopy in the Management of the Adnexal Mass and Staging of Gynecologic Cancers

J. Fowler, T. Manolitsas, 2001, Clinical obstetrics and gynecology.

Fertility-sparing surgery for early-stage cervical cancer: does surgical approach have an impact on disease outcomes?

J. Fowler, K. Bixel, 2019, American journal of obstetrics and gynecology.

Flow Characteristics in Benign and Malignant Gynecologic Tumors Using Transvaginal Color Flow Doppler

L. Twiggs, J. Carter, E. Hartenbach, 1994, Obstetrics and gynecology.

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Danielle M. Enserro, B. Monk, R. Burger, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.

R. Coleman, P. Judson, Shamshad Ali, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment surgical staging of patients with cervical carcinoma

L. Twiggs, P. Paley, J. Fowler, 1998, Cancer.

Are prediction models for Lynch syndrome valid for probands with endometrial cancer?

H. Hampel, D. Cohn, F. Backes, 2009, Familial Cancer.

Robotic radical hysterectomy and pelvic lymphadenectomy for uterine rhabdomyosarcoma

F. Backes, J. Fowler, L. Seamon, 2008, Journal of robotic surgery.

Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients.

W. Frankel, A. de la Chapelle, H. Nakagawa, 2007, Cancer research.

Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).

David W. Cohen, D. Cohn, R. Salani, 2019, Gynecologic oncology.

Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.

E. Eisenhauer, D. Cohn, R. Salani, 2013, Gynecologic oncology.

Chylous ascites following treatment for gynecologic malignancies.

J. Fowler, S. Abdessalam, T. Manolitsas, 2002, Gynecologic oncology.

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer.

E. Hade, E. Eisenhauer, D. Cohn, 2012, Gynecologic oncology.

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

B. Monk, R. Burger, R. Mannel, 2013, Gynecologic oncology.

Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.

Wei Chen, P. Goodfellow, W. Frankel, 2017, Gynecologic oncology.

The prognostic significance of the triple negative phenotype in endometrial cancer.

C. Morrison, D. Cohn, D. O’Malley, 2010, Gynecologic oncology.

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.

B. Monk, R. Burger, G. Fleming, 2015, Gynecologic oncology.

Endometrial Cancer: Who lives, who dies, can we improve their story?

P. Goodfellow, D. Cohn, F. Backes, 2021, The oncologist.

Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery.

D. Cohn, R. Holloway, F. Backes, 2013, Gynecologic oncology.

Wound complications following vulvar excision for nonmalignant lesions

D. Cohn, F. Backes, D. O’Malley, 2021, AJOG global reports.

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.

R. Coleman, P. Judson, Shamshad Ali, 2013, Gynecologic oncology.

Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.

M. Grever, C. Shapiro, T. Bekaii-Saab, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis.

C. Morrison, N. Ramirez, J. Pavelka, 2005, American journal of obstetrics and gynecology.

Activity of weekly paclitaxel in patients with advanced endometrial cancer previously treated with both a platinum agent and paclitaxel.

M. Markman, J. Fowler, 2004, Gynecologic oncology.

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer.

M. Callahan, G. Sutton, E. Eisenhauer, 2011, Gynecologic Oncology.

Colorectal Cancer ) among Endometrial Cancer Patients Screening for Lynch Syndrome ( Hereditary Nonpolyposis

W. Frankel, H. Nakagawa, Janet C Lockman, 2006 .

Swelling Among Women Who Need Education About Leg Lymphedema: A Descriptive Study of Lymphedema in Women Undergoing Surgery for Endometrial Cancer

E. Hade, M. Katz, R. Salani, 2014, International Journal of Gynecologic Cancer.

Direct and Buffering Effects of Social Support Among Gynecologic Cancer Survivors

B. Andersen, K. Carpenter, G. Maxwell, 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Surgery: Role of lymphadenectomy in the staging of endometrial cancer

D. Cohn, J. Fowler, K. Resnick, 2009, Nature Reviews Clinical Oncology.

Sexual Self Schema as a Moderator of Sexual and Psychological Outcomes for Gynecologic Cancer Survivors

B. Andersen, K. Carpenter, G. Maxwell, 2009, Archives of sexual behavior.

Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer.

C. Morrison, W. Frankel, D. Cohn, 2010, Gynecologic oncology.

Sexual Morbidity Associated With Poorer Psychological Adjustment Among Gynecological Cancer Survivors

B. Andersen, K. Carpenter, G. Maxwell, 2010, International Journal of Gynecologic Cancer.

Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.

N. Ramirez, J. Pavelka, D. Cohn, 2004, Gynecologic oncology.

Incorporating resident/fellow training into a robotic surgery program

Martin Martino, M. Martino, R. Salani, 2015, Journal of surgical oncology.

Resilience, hope and flourishing are inversely associated with burnout among members of the Society for Gynecologic Oncology

J. Fowler, M. Vetter, M. Vetter, 2018, Gynecologic oncology reports.

Quality assurance of second opinion pathology in gynecologic oncology.

A. Selman, J. Fowler, T. Niemann, 1999, Obstetrics and gynecology.

Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.

L. Twiggs, J. Carlson, J. Carter, 1995, American journal of obstetrics and gynecology.

Mixed mesodermal sarcoma of the ovary in a young patient.

J. Berek, R. Nieberg, J. Fowler, 1996, European Journal of Obstetrics, Gynecology, and Reproductive Biology.

Physical Sequelae and Depressive Symptoms in Gynecologic Cancer Survivors: Meaning in Life as a Mediator

B. Andersen, G. Maxwell, J. Fowler, 2008, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Improved Survival With an Intact DNA Mismatch Repair System in Endometrial Cancer

C. Morrison, W. Frankel, H. Hampel, 2006, Obstetrics and gynecology.

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.

A. Norman, P. D. Peppercorn, P. Quirke, 2007, Radiology.

The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer.

G. Phillips, E. Eisenhauer, D. Cohn, 2013, Gynecologic oncology.

Hysterectomy for the Treatment of Gynecologic Malignancy

F. Backes, J. Fowler, 2014, Clinical obstetrics and gynecology.

A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer.

S. Bergese, M. Abdel-Rasoul, E. Eisenhauer, 2016, Journal of minimally invasive gynecology.

The Gynecologic Oncology Consult: Symptom Presentation and Concurrent Symptoms of Depression and Anxiety

D. Golden-Kreutz, B. Andersen, Parul Gupta, 2004, Obstetrics and gynecology.

Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.

D. Cohn, D. O’Malley, J. Fowler, 2009, Gynecologic oncology.

Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.

R. Burger, R. Ozols, R. Mannel, 2005, Gynecologic oncology.

Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).

David W. Cohen, D. Cohn, R. Salani, 2019, Gynecologic oncology.

The Effect of Prolonged Cycles of Chemotherapy on Quality of Life in Gynaecologic Cancer Patients

L. Twiggs, J. Fowler, L. Carson, 1997, The journal of obstetrics and gynaecology research.

Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.

P. Grigsby, J. Rader, R. Mannel, 2009, Gynecologic oncology.

A novel technique to minimize contamination for cervical cancer surgery patients.

M. Martino, M. Thomas, J. Fowler, 2020, Journal of minimally invasive gynecology.

Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

E. Hade, D. Cohn, R. Salani, 2015, International Journal of Gynecologic Cancer.

Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality care.

E. Eisenhauer, D. Cohn, R. Salani, 2013, Gynecologic oncology.

Management of pelvic venous stenosis with intravascular stainless steel stents.

L. Twiggs, K. Dusenbery, D. Hunter, 1995, Gynecologic oncology.

Should Bevacizumab Be Continued After Progression on Bevacizumab in Recurrent Ovarian Cancer?

E. Eisenhauer, D. Cohn, R. Salani, 2013, International Journal of Gynecologic Cancer.

Feasibility of Interval Cytoreduction Following Neoadjuvant Chemotherapy With Carboplatin, Weekly Paclitaxel, and Bevacizumab for Advanced Ovarian Cancer—A Phase 1 Study

E. Eisenhauer, D. Cohn, R. Salani, 2014, International Journal of Gynecologic Cancer.

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.

V. Zanagnolo, D. Cohn, F. Backes, 2008, Gynecologic oncology.

Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?

D. Cohn, F. Backes, D. O’Malley, 2010, Gynecologic oncology.

Outpatient Platinum-Taxane Intraperitoneal Chemotherapy Regimen for Ovarian Cancer

D. Cohn, D. O’Malley, J. Fowler, 2009, International Journal of Gynecologic Cancer.

Ureteroileoneocystostomy: the use of an ileal segment for ureteral substitution in gynecologic oncology.

D. Cohn, J. Fowler, L. Copeland, 2002, Gynecologic oncology.

Cancer in the Pregnant Patient

D. O’Malley, J. Fowler, Kenneth H. Kim, 2011 .

Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.

Jeffrey M. Fowler, Nina A. Mayr, Jian Z. Wang, 2010, International journal of radiation oncology, biology, physics.

B. Monk, T. Kolevska, M. Morgan, 2017 .

The Role of Operative Laparoscopy in Gynecologic Oncology

E. Hartenbach, J. Fowler, 1996, Diagnostic and Therapeutic Endoscopy.

Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.

G. Phillips, E. Eisenhauer, P. Muscarella, 2013, Gynecologic oncology.

Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study

B. Monk, R. Burger, Joan L. Walker, 2011 .

CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.

D. Cohn, D. O’Malley, J. Fowler, 2008, Gynecologic oncology.

Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation

E. Eisenhauer, C. Lynch, D. Cohn, 2015, International Journal of Gynecologic Cancer.

Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.

Jian Z. Wang, W. Yuh, N. Mayr, 2010, International journal of radiation oncology, biology, physics.

Late side effects of robotic surgery.

F. Backes, J. Fowler, 2016, Gynecologic oncology.

Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers

A. Stuckey, D. Levine, A. Secord, 2018, Gynecologic Oncology.

Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer

Lai Wei, D. Cohn, R. Salani, 2019, Gynecologic Oncology.

Burnout and associated factors among members of the Society of Gynecologic Oncology.

G. Phillips, K. Carpenter, J. Fowler, 2015, American journal of obstetrics and gynecology.

Cost-Effectiveness Analysis of Strategies for the Surgical Management of Grade 1 Endometrial Adenocarcinoma

D. Cohn, W. Huh, J. Fowler, 2007, Obstetrics and gynecology.